TLPH Stock Analysis: Buy, Sell, or Hold?
TLPH - Talphera, Inc. Common Stock
$1.42
-0.04 (-2.74%)
▼
5d:
+20.34%
30d:
+75.68%
90d:
+86.69%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 13, 2026
29d
Get Alerted When TLPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TLPH is 21.4% above its trading range ($1.17). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TLPH is 21.4% above its trading range ($1.17). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TLPH is currently trading at $1.42, which is considered extended relative to its 30-day fair value range of $0.81 to $1.17.
Technical Outlook: Technically, TLPH is in a downtrend. The price is approaching resistance at $0.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.17 (+123.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TLPH is in a downtrend. The price is approaching resistance at $0.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TLPH has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.17 (+123.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.81 -
$1.17
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+21.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 123.0% below Wall St target ($3.17)
- WARNING: Recommendation downgraded due to 21.4% overvaluation
Trading Range Analysis
30-Day Trading Range
$0.81 -
$1.17
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$0.90
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.26
Wall Street Target
$3.17
(+123.0%)
Share & Embed Analysis
Last updated: July 14, 2026 8:08 AM ET
Data refreshes hourly during market hours. Next update: 9:08 AM
Data refreshes hourly during market hours. Next update: 9:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TLPH showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Vincent J Angotti
BUY
213310 shares
2026-03-13
Badri N Dasu
BUY
35000 shares
2026-02-12
Raffi Asadorian
BUY
45000 shares
2026-02-12
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
